Alaleh Raji
Overview
Explore the profile of Alaleh Raji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rieckmann P, Ziemssen T, Penner I, Raji A, Wagner T, Richter J, et al.
Adv Ther
. 2022 Apr;
39(6):2749-2760.
PMID: 35428903
Introduction: Consistent treatment adherence is an important determinant of durable response in multiple sclerosis (MS). Published data indicate that adherence to > 80% of prescribed doses may be considered optimal....
2.
Raji A, Ostwaldt A, Opfer R, Suppa P, Spies L, Winkler G
Front Neurol
. 2018 Aug;
9:545.
PMID: 30140245
Thalamic atrophy and whole brain atrophy in multiple sclerosis (MS) are associated with disease progression. The motivation of this study was to propose and evaluate a new grouping scheme which...
3.
Spies L, Tewes A, Suppa P, Opfer R, Buchert R, Winkler G, et al.
Phys Med Biol
. 2013 Nov;
58(23):8323-37.
PMID: 24216694
A novel method is presented for fully automatic detection of candidate white matter (WM) T1 hypointense lesions in three-dimensional high-resolution T1-weighted magnetic resonance (MR) images. By definition, T1 hypointense lesions...
4.
Gold S, Raji A, Huitinga I, Wiedemann K, Schulz K, Heesen C
J Neuroimmunol
. 2005 Jun;
165(1-2):186-91.
PMID: 15935481
Clinical studies have shown that groups of multiple sclerosis (MS) patients exhibit a chronically activated hypothalamo-pituitary-adrenal (HPA) axis. However, the association of HPA axis activity and disease progression in MS...
5.
Heesen C, Gold S, Raji A, Wiedemann K, Schulz K
Psychoneuroendocrinology
. 2002 Mar;
27(4):505-17.
PMID: 11912002
Hypothalamo-pituitary-adrenal (HPA) dysregulation has recently been demonstrated in multiple sclerosis (MS) by means of combined dexamethasone corticotropin-releasing hormone (Dex-CRH) suppression tests. Authors found a correlation with course of disease and...